<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

The Cancer Letter

Study Links Obesity To Higher Risk of Ovarian Cancer

January 30, 2009

FDA Ponders Standards For “Retrospective Prospective” Studies

January 30, 2009

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

ODAC Discussion: NCI’s Richard Simon Cautions About Rules Of Thumb

January 30, 2009

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

January 30, 2009

Early HER2 Positive Patients At Higher Risk of Recurrence

January 30, 2009

Tykerb Plus Letrozole Delayed Metastatic Breast Cancer

January 30, 2009

Estrogen Can Benefit Women With Metastatic Breast Cancer

January 30, 2009

Alternating Mammography, MRI Tested For High-Risk Women

January 30, 2009

Degarelix Approved For Advanced Prostate Cancer

January 30, 2009